Holen Sie sich die Stockscreener-App
424.30
2.16%
-9.77
Alnylam Pharmaceuticals Inc Aktie (ALNY) Neueste Nachrichten
Top 20 biopharma companies Q3 2025 market cap up 4% despite headwinds - Yahoo Finance
Alnylam (NASDAQ: ALNY) to present Nov 10 & Nov 19 at UBS and Jefferies; live webcasts - Stock Titan
Alnylam to Webcast Presentations at Upcoming November Investor Conferences - Business Wire
Royalty Pharma Acquires $310 Million Royalty Interest in Alnylam's AMVUTTRA from Blackstone Life Sciences - Quiver Quantitative
Hussman Strategic Advisors Inc. Sells 2,100 Shares of Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat
Why global investors buy Alnylam Pharmaceuticals Inc. (DUL) stock2025 Volatility Report & Weekly High Momentum Picks - newser.com
Is Alnylam Pharmaceuticals Inc. reversing from oversold territoryInflation Watch & Low Drawdown Investment Ideas - newser.com
Amalgamated Bank Boosts Holdings in Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat
Assetmark Inc. Increases Holdings in Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat
Regression analysis insights on Alnylam Pharmaceuticals Inc. performancePortfolio Gains Report & Daily Risk Controlled Trade Plans - newser.com
Can Alnylam Pharmaceuticals Inc. (DUL) stock sustain revenue momentumWeekly Stock Report & Real-Time Sentiment Analysis - newser.com
Will Alnylam Pharmaceuticals Inc. continue its uptrendMarket Activity Summary & Fast Exit/Entry Strategy Plans - newser.com
Is Alnylam Pharmaceuticals Inc. stock dividend yield sustainableJuly 2025 Review & Target Return Focused Picks - newser.com
New Novartis data at ASN Kidney Week and AHA Scientific Sessions demonstrate momentum of broad CRM portfolio and pipeline - GlobeNewswire Inc.
How to monitor Alnylam Pharmaceuticals Inc. with trend dashboards2025 Price Action Summary & Weekly Chart Analysis and Trade Guides - newser.com
What data driven models say about Alnylam Pharmaceuticals Inc.’s futureTreasury Yields & Fast Exit and Entry Trade Guides - newser.com
What RSI levels show for Alnylam Pharmaceuticals Inc. (DUL) stock2025 Stock Rankings & Long-Term Investment Growth Plans - newser.com
Combining machine learning predictions for Alnylam Pharmaceuticals Inc.2025 Market Sentiment & Stepwise Entry and Exit Trade Signals - newser.com
Tredje AP fonden Has $3.98 Million Position in Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat
Alnylam (ALNY) Dropped from Goldman Sachs Conviction List - GuruFocus
How to recover losses in Alnylam Pharmaceuticals Inc. stock2025 Bull vs Bear & Comprehensive Market Scan Reports - newser.com
Can Alnylam Pharmaceuticals Inc. (DUL) stock sustain institutional flowsJuly 2025 Big Picture & AI Enhanced Trading Alerts - newser.com
Has Alnylam Pharmaceuticals Inc. found a price floorJuly 2025 News Drivers & Weekly High Return Stock Forecasts - newser.com
Sumitomo Life Insurance Co. Makes New Investment in Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat
Published on: 2025-11-03 03:21:20 - newser.com
Is Alnylam Pharmaceuticals Inc. stock resilient to inflationJuly 2025 Sentiment & AI Driven Stock Price Forecasts - newser.com
How dovish Fed policy supports Alnylam Pharmaceuticals Inc. (DUL) stock2025 Historical Comparison & Real-Time Stock Entry Alerts - newser.com
Envestnet Asset Management Inc. Buys 23,749 Shares of Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat
How risky is Alnylam Pharmaceuticals Inc. (DUL) stock compared to peersEarnings Overview Report & Precise Buy Zone Tips - newser.com
Is it time to cut losses on Alnylam Pharmaceuticals Inc.July 2025 Earnings & Fast Entry and Exit Trade Plans - newser.com
Using data filters to optimize entry into Alnylam Pharmaceuticals Inc.July 2025 Drop Watch & Stepwise Trade Execution Plans - newser.com
What downside risks could hit Alnylam Pharmaceuticals Inc. (DUL) stockOptions Play & Free Community Supported Trade Ideas - newser.com
Is Alnylam Pharmaceuticals Inc. (DUL) stock overpriced at current multiplesQuarterly Trade Summary & Community Consensus Trade Signals - newser.com
Alnylam Pharmaceuticals Hits Day Low of $436.51 Amid Price Pressure - Markets Mojo
Alnylam Pharmaceuticals, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For Next Year - Yahoo Finance
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet - Benzinga
ANTIPODES PARTNERS Ltd Sells 36,750 Shares of Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat
Is Alnylam Pharmaceuticals Inc. (DUL) stock vulnerable to rate hikes2025 Technical Overview & High Accuracy Trade Alerts - newser.com
Strs Ohio Has $9.83 Million Holdings in Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat
Focus Partners Advisor Solutions LLC Has $263,000 Holdings in Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Why Alnylam Pharmaceuticals Inc. stock is recommended by analystsJuly 2025 Review & Capital Efficiency Focused Strategies - newser.com
What to do if you’re stuck in Alnylam Pharmaceuticals Inc.Wall Street Watch & Low Drawdown Investment Ideas - newser.com
Alnylam Pharmaceuticals (NASDAQ:ALNY) Downgraded to Buy Rating by Wall Street Zen - MarketBeat
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q3 2025 Earnings Call Transcript - Insider Monkey
A Fresh Look at Alnylam Pharmaceuticals (ALNY) Valuation Following Q3 Profit Surge and Upgraded Guidance - simplywall.st
1.23%
2.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):